-
Jio Platforms
1,490.00 1,423.80(%) -
Reliance Industries
1,182.00 1,611.20(%) -
NSE
1,795.00 1,878.00(%) -
Aeroflex
579.00 613.50(%) -
The Bombay Burmah
1,203.00 2,050.25(%) -
Pidilite Inds.
1,344.00 1,259.45(%) -
Dalmia BharatLtd
1,403.50 1,464.85(%) -
Cholaman.Inv.&Fn
1,589.95 1,952.00(%) -
Bajaj Finance
931.00 1,177.60(%) -
Max Healthcare
865.95 1,196.50(%) -
Birlasoft Ltd
345.00 473.75(%) -
M & M Fin. Serv.
256.60 253.30(%) -
JSW Dulux
286.50 374.67(%) -
Tube Investments
2,098.60 2,006.00(%) -
Acutaas Chemical
4,000.00 3,977.00(%) -
Adani Ports
1,839.80 1,891.80(%) -
Moneyview
52.44 65.43(%) -
Tonbo Imaging
1,175.75 1,013.95(%) -
Apollo Hospitals
8,239.00 9,326.80(%) -
DLF
674.90 786.40(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Welcure Drugs & Pharmaceuticals Ltd Trading
- Indian Private
- BSE Code : 4125.0
- ISIN : INE331C01025
-
Today’s Low
0.18 -
Today’s High
0.19
-
Open
0.19 -
Perv Close
0.19 -
52W Low
0.17 -
52W High
0.64
Key Indicators
-
P/E(TTM)
0.00
-
Mar.Cap (₹Cr.)
23.48
-
Div & Yield %
0.00
-
Book Value(₹)
0.79
-
Debt-Equity Ratio
0.00
-
AGM Date
28-Oct-2026
-
EPS
0.00
-
P/E Ratio
0.00
Financials Ratios
-
Debt-Equity Ratio
-
-
Mar.Cap (₹Cr.)
23.48
-
RONW (%)
-
-
ROCE (%)
-
Score Board
-
Equity (₹ in Cr.)
123.59
-
BV (₹)
0.80
-
Sales( ₹ in Cr.)
365.54
-
NP (in Cr.)
-5.49
-
NP Var(%)
-353.0
-
Div%
0.0
-
CPS (₹)
0.00
-
EPS (₹)
0.00
-
Traded Value (₹ in Lakhs)
23.48
-
52 Week High
0.64
-
52 Week Low
0.17
-
Price BSE
0.0
-
Price NSE
0.00
-
Market Capital( in Cr.)
23.48
-
P/C Ratio
0.00
-
P/E Ratio
0.00
-
Price Vs.BV
0.00
-
30-May-2026( 03:45)
Results - Announcements - Welcu... - Net loss of Welcure Drugs & Ph...
-
23-May-2026( 05:06)
Corporate News - Welcu... - Welcure Drugs & Pharmaceutical...
-
07-Feb-2026( 04:51)
Corporate News - Welcu... - Welcure Drugs & Pharmaceutical...
-
02-Dec-2025( 12:06)
Corporate News - Welcu... - Welcure Drugs & Pharmaceutical...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 24.55 | 0.00 | 0.00 | 0.11 | 0.13 | 0.08 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 24.55 | 0.00 | 0.00 | 0.11 | 0.13 | 0.08 |
| Other Income | 1.91 | 0.09 | 0.24 | 0.00 | 0.00 | 0.00 |
| Stock Adjustments | 143.52 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income | 169.98 | 0.09 | 0.24 | 0.11 | 0.13 | 0.08 |
| EXPENDITURE : | ||||||
| Raw Materials | 164.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Power and Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Employee Cost | 0.09 | 0.08 | 0.03 | 0.00 | 0.00 | 0.00 |
| Other Manufacturing Expenses | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling and Administration Expenses | 2.78 | 0.13 | 0.10 | 0.08 | 0.08 | 0.09 |
| Miscellaneous Expenses | 0.17 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Employee Benefit Expenses | 0.09 | 0.08 | 0.03 | 0.00 | 0.00 | 0.00 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 167.11 | 0.23 | 0.13 | 0.08 | 0.08 | 0.09 |
| Operating Profit | 2.88 | -0.14 | 0.10 | 0.02 | 0.06 | -0.01 |
| Interest | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 2.79 | -0.14 | 0.10 | 0.02 | 0.06 | -0.01 |
| Depreciation | 0.01 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit Before Tax | 2.78 | -0.18 | 0.10 | 0.02 | 0.06 | -0.01 |
| Current Tax | 0.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Net Profit | 2.17 | -0.17 | 0.10 | 0.02 | 0.06 | -0.01 |
| Extraordinary Items | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 |
| Adjusted Net Profit | 2.17 | -0.17 | 0.08 | 0.02 | 0.06 | -0.01 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance brought forward | -12.25 | -12.07 | -12.18 | -12.20 | -12.25 | -12.25 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | -10.08 | -12.25 | -12.07 | -12.18 | -12.20 | -12.25 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 0.19 | -0.13 | 0.08 | 0.02 | 0.05 | -0.01 |
| Earnings Per Share(Adj)-Unit Curr | 0.02 | -0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Book Value | 9.12 | 1.00 | 1.13 | 0.08 | 0.06 | 0.01 |
| Book Value(Adj)-Unit Curr | 0.83 | 0.09 | 0.10 | 0.01 | 0.01 | 0.00 |
